KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Teva Pharmaceutical Industries (TEVA) Asset Utilization Ratio (2016 - 2026)

Teva Pharmaceutical Industries filings provide 18 years of Asset Utilization Ratio readings, the most recent being 0.43 for Q1 2026.

  • On a quarterly basis, Asset Utilization Ratio rose 9.21% to 0.43 in Q1 2026 year-over-year; TTM through Mar 2026 was 0.43, a 9.21% increase, with the full-year FY2025 number at 0.43, up 7.87% from a year prior.
  • Asset Utilization Ratio hit 0.43 in Q1 2026 for Teva Pharmaceutical Industries, roughly flat from 0.43 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.43 in Q1 2026 to a low of 0.33 in Q1 2022.
  • Median Asset Utilization Ratio over the past 5 years was 0.37 (2024), compared with a mean of 0.37.
  • The widest YoY moves for Asset Utilization Ratio: up 14.1% in 2025, down 4.32% in 2025.
  • Teva Pharmaceutical Industries' Asset Utilization Ratio stood at 0.34 in 2022, then grew by 9.5% to 0.37 in 2023, then increased by 1.33% to 0.38 in 2024, then increased by 14.1% to 0.43 in 2025, then increased by 0.3% to 0.43 in 2026.
  • The last three reported values for Asset Utilization Ratio were 0.43 (Q1 2026), 0.43 (Q4 2025), and 0.39 (Q3 2025) per Business Quant data.